The invention relates to a modified recombinant adenovirus as well as a preparation method and application thereof, after an adenovirus vector is modified, the surface
negative charge level of adenovirus particles can be reduced, and further the interaction between the adenovirus vector and PF4 (
platelet factor 4) is reduced. After the modified adenovirus vector is administrated, the risk of
thrombus can be reduced, the safety and effectiveness of vaccines are improved, and the modified adenovirus vector is more suitable for high-risk people such as old people, children and pregnant women. The recombinant adenovirus disclosed by the invention can be widely applied to
gene therapy, tumor immunization and / or antiviral immunization, including
initiation of primary immune response and
initiation of booster immune response in human or mammals, and is used for destroying the tolerance of hosts to autoantigens. The modified recombinant adenovirus can be used for developing
mucous membrane administration preparations. Compared with injection, the mucosal administration preparation has compliance, the administration dosage is lower, and triple protection effects of
humoral immunity,
cellular immunity and
mucosal immunity can be achieved.